Search
for
Sort by
Research 601–630 of 921
- Successful Treatment of Pediatric Alopecia Areata of the Scalp Using Topical Bimatoprost
- Chemotherapy-Induced Eyebrow Alopecia and Psychological Recovery: Permanent Micropigmentation as a Component of Multidisciplinary Oncological Rehabilitation
- A placebo-controlled, double-blind crossover study of fluoxetine in trichotillomania
- Evaluation of SALT score severity in correlation with trichoscopic findings in alopecia areata: a study of 303 patients
- Acquired trichomegaly of the eyelashes and hypertrichosis induced by bimatoprost
- Alopecia areata: An update
- Update on the Treatment of Alopecia Areata
- Novel therapies for alopecia areata: The era of rational drug development
- Alopecia Areata Update
- Alopecia Areata
- Dermatologic Adverse Events from Cancer Treatments
- A clinical study on alopecia areata
- Significant improvement with ivarmacitinib after suboptimal response to tofacitinib in severe alopecia areata: a case report and literature review
- Dermatosurgical techniques for repigmentation of vitiligo
- Ocular Cosmetics in Modern Times
- Oral isotretinoin combined with topical clobetasol 0.05% and tacrolimus 0.1% for the treatment of frontal fibrosing alopecia: a randomized controlled trial
- Anticytokine therapy, particularly anti-IFN-γ, in Th1-mediated autoimmune diseases
- Dermatologic Manifestations of Human Immunodeficiency Virus Infection
- Compounding as a Current Therapeutic Option in Dermatology
- Case Report: Vitiligo and Alopecia Universalis Following Rituximab Therapy in a Patient with Myasthenia Gravis
- An Update on Drug-Induced Pigmentation
- Improvement in health‐related quality of life and symptoms of anxiety and depression in patients with alopecia areata randomized to baricitinib or placebo: Results from two international randomized controlled trials
- Alopecia Universalis Successfully Treated With Adalimumab
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial
- Effectiveness of Baricitinib on Nail Alopecia Areata: A 48-Week Single-Center Retrospective Study
- 51840 Efficacy of the Oral JAK1/JAK2 Inhibitor Deuruxolitinib in Adult Patients with Moderate to Severe Alopecia Areata: Pooled Results from the Multinational Double-Blind, Placebo-Controlled THRIVE-AA1 and THRIVE-AA2 Phase 3 Trials
- Baricitinib for the Treatment of Alopecia Areata
- Ritlecitinib for the Management of Alopecia Areata: A Narrative Review of Real-World Evidence and Selected Post Hoc Analyses
- Perceived Stigma and Mental Health Disorders Among Adults With Alopecia Areata Living in Japan
- Management of comorbid Crohn's disease and alopecia universalis with upadacitinib and oral minoxidil.